Agenus (AGEN) Return on Capital Employed Growth (3y) (2014 - 2026)
Agenus (AGEN) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,094.26 Bn | 68,093.97 Bn | - | - |
| 2 | Nanobiotix | 1,939.09 Bn | 1,939.02 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 123.34 Bn | 116.09 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.38 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.96 Bn | 62.96 Bn | - | - |
| 8 | Argenx Se | 56.38 Bn | 51.20 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | 4,853.00 |
| 10 | Agenus | 229.54 Mn | 194.55 Mn | 33.74 Mn | 6,997.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,997.00 |
| Dec 31, 2025 | 6,460.00 |
| Sep 30, 2025 | 3,625.00 |
| Jun 30, 2025 | -6,462.00 |
| Mar 31, 2025 | -205,680.00 |
| Dec 31, 2024 | -110,640.00 |
| Sep 30, 2024 | -7,286.00 |
| Jun 30, 2024 | -260,726.00 |
| Mar 31, 2024 | -32,047.00 |
| Dec 31, 2023 | -8,466.00 |
| Sep 30, 2023 | 10,577.00 |
| Jun 30, 2023 | 23,244.00 |
| Mar 31, 2023 | 21,761.00 |
| Dec 31, 2022 | 12,069.00 |
| Sep 30, 2022 | 9,099.00 |
| Jun 30, 2022 | 9,542.00 |
| Mar 31, 2022 | 7,611.00 |
| Dec 31, 2021 | 19,813.00 |
| Sep 30, 2021 | 19,189.00 |
| Jun 30, 2021 | -21,636.00 |